Business Description
![Profound Medical Corp Profound Medical Corp logo](https://static.gurufocus.com/logos/0C0000AQKV.png?14)
Profound Medical Corp
NAICS : 621511
SIC : 8689
ISIN : CA74319B1067
Description
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 5.12 | |||||
Equity-to-Asset | 0.78 | |||||
Debt-to-Equity | 0.17 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.11 | |||||
Beneish M-Score | -2.96 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -5.5 | |||||
3-Year EBITDA Growth Rate | -5.5 | |||||
3-Year EPS without NRI Growth Rate | -6.8 | |||||
3-Year FCF Growth Rate | 3.1 | |||||
3-Year Book Growth Rate | -31.8 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.57 | |||||
Future 3-5Y Total Revenue Growth Rate | 98.16 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 28.83 | |||||
9-Day RSI | 36.28 | |||||
14-Day RSI | 41.35 | |||||
6-1 Month Momentum % | 32 | |||||
12-1 Month Momentum % | 32.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.61 | |||||
Quick Ratio | 7.42 | |||||
Cash Ratio | 6.05 | |||||
Days Inventory | 861.64 | |||||
Days Sales Outstanding | 310.34 | |||||
Days Payable | 316.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -1.9 | |||||
Shareholder Yield % | -10.86 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 61.29 | |||||
Operating Margin % | -388.85 | |||||
Net Margin % | -349.82 | |||||
FCF Margin % | -289.27 | |||||
ROE % | -69.48 | |||||
ROA % | -53.53 | |||||
ROIC % | -217.86 | |||||
ROC (Joel Greenblatt) % | -235.31 | |||||
ROCE % | -68.32 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 26.17 | |||||
PB Ratio | 5.56 | |||||
Price-to-Tangible-Book | 5.61 | |||||
EV-to-EBIT | -6.45 | |||||
EV-to-EBITDA | -6.72 | |||||
EV-to-Revenue | 24.53 | |||||
EV-to-Forward-Revenue | 17.19 | |||||
EV-to-FCF | -8.48 | |||||
Price-to-Net-Current-Asset-Value | 5.79 | |||||
Price-to-Net-Cash | 9.4 | |||||
Earnings Yield (Greenblatt) % | -15.5 | |||||
FCF Yield % | -10.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Profound Medical Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 10.678 | ||
EPS (TTM) (C$) | -1.651 | ||
Beta | 0.38 | ||
Volatility % | 58.5 | ||
14-Day RSI | 41.35 | ||
14-Day ATR (C$) | 0.688858 | ||
20-Day SMA (C$) | 13.3415 | ||
12-1 Month Momentum % | 32.95 | ||
52-Week Range (C$) | 9.55 - 16 | ||
Shares Outstanding (Mil) | 24.48 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Profound Medical Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Profound Medical Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Profound Medical Corp Frequently Asked Questions
What is Profound Medical Corp(TSX:PRN)'s stock price today?
The current price of TSX:PRN is C$12.22. The 52 week high of TSX:PRN is C$16.00 and 52 week low is C$9.55.
When is next earnings date of Profound Medical Corp(TSX:PRN)?
The next earnings date of Profound Medical Corp(TSX:PRN) is 2024-11-01 Est..
Does Profound Medical Corp(TSX:PRN) pay dividends? If so, how much?
Profound Medical Corp(TSX:PRN) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |